Blog Viewer

Effect of Intravenous Tenecteplase Dose on Cerebral Reperfusion Before Thrombectomy in Patients With Large Vessel Occlusion Ischemic Stroke

By Currents Editor posted 03-02-2020 10:13


Journal of the American Medical Association (02/20/20) doi: 10.1001/jama.2020.1511

Campbell, Bruce C. V.; Mitchell, Peter J.; Churilov, Leonid; et al.

While I.V. thrombolysis with tenecteplase is superior to alteplase in improving cerebral reperfusion in ischemic stroke patients, it was unknown if tenecteplase's performance is influenced by dose. To explore, researchers in Australia and New Zealand assembled a trial population of 300 adults with ischemic stroke caused by large vessel occlusion. Participants in the EXTEND-IA TNK study Part II were randomized by a ratio of 1:1 to receive either 0.40 mg/kg or 0.25 mg/kg of tenecteplase, administered as a bolus before endovascular thrombectomy. The primary endpoint was reperfusion of more than 50% of the involved ischemic territory before thrombectomy. The share of patients who satisfied this goal was 19.3% for both groups, signifying no additional benefit to giving patients a higher dose.


Jamie Nicole LaBuzetta, MD, MSc, MPhil UC San Diego, Dept of Neurosciences, Division of Neurocritical Care Informed consent is the complex basis of shared decision-making in the medical realm. It involves sharing information with a patient or surrogate decision-maker and asking for permission ...
By Shraddha Mainali, MD; Sherry Chou, MD, MSc; Molly McNett, PhD, RN, CNRN, FNCS, FAAN; Raimund Helbok, MD, PhD; Jennifer Frontera, MD; Ericka L. Fink, MD, MS; Michelle Schober, MD; and Courtney L. Robertson, MD Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), or the COVID-19 pandemic, ...
Taking a Closer Look into Neurocritical Care Mechanical Ventilation During the COVID19 Pandemic and the Use of Anesthesia Machines in the Neuro ICU By Shaun Golden, MSN, RN; and Sarah Beth Thomas, MSN, RN, CCRN, CNRN, SCRN Since the beginning of the COVID-19 global pandemic, ventilators ...